Cell-penetrating Peptide for Enhanced Delivery of Nucleic Acids and Drugs to Ocular Tissues Including Retina and Cornea
Open Access
- 1 January 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (1) , 107-114
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Endophthalmitis Associated With Intravitreal InjectionsInternational Ophthalmology Clinics, 2007
- Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1Biochemical and Biophysical Research Communications, 2006
- Ranibizumab: treatment in patients with neovascular age-related macular degenerationExpert Opinion on Biological Therapy, 2006
- Macular degeneration: recent advances and therapeutic opportunitiesNature Reviews Neuroscience, 2006
- Biological activity of Tat (47–58) peptide on human pathogenic fungiBiochemical and Biophysical Research Communications, 2006
- Cell-penetrating PeptidesJournal of Biological Chemistry, 2003
- Ability of the Tat Basic Domain and VP22 To Mediate Cell Binding, but Not Membrane Translocation of the Diphtheria Toxin A-FragmentBiochemistry, 2001
- Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral VectorsHuman Gene Therapy, 1996
- Increased Retinal Synthesis of Heparan Sulfate Proteoglycan and HNK‐1 Glycoproteins Following Photoreceptor DegenerationJournal of Neurochemistry, 1994
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988